Real World Superiority Data May Not Be Enough To Boost GSK's Breo In COPD

Breo Ellipta is associated with a lower rate of exacerbations in real world Salford study, but some analysts question whether it's too late to turn performance around in a highly competitive, highly price-conscious market.